| Literature DB >> 20111881 |
T J Meerhoff1, M L Houben, F E J Coenjaerts, J L L Kimpen, R W Hofland, F Schellevis, L J Bont.
Abstract
In this study, we present the multiple detection of respiratory viruses in infants during primary respiratory illness, investigate the sensitivity of nasal swabs and nasopharyngeal aspirates, and assess whether patient characteristics and viral load played a role in the sensitivity. Healthy infants were included at signs of first respiratory tract infection. Paired nasopharyngeal aspirates and nasal swabs were collected. Real-time polymerase chain reaction (PCR) was carried out for 11 respiratory pathogens. Paired nasopharyngeal aspirates and nasal swabs were collected in 98 infants. Rhinovirus (n = 67) and respiratory syncytial virus (n = 39) were the most frequently detected. Co-infection occurred in 48% (n = 45) of the infants. The sensitivity of the nasal swab was lower than the nasopharyngeal aspirate, in particular, for respiratory syncytial virus (51% vs. 100%) and rhinovirus (75% vs. 97%). The sensitivity of the nasal swab was strongly determined by the cycle threshold (CT) value (p < 0.001). The sensitivity of the swab for respiratory syncytial virus, but not rhinovirus, was 100% in children with severe symptoms (score >or=11). It is concluded that, for community-based studies and surveillance purposes, the nasal swab can be used, though the sensitivity is lower than the aspirate, in particular, for the detection of mild cases of respiratory syncytial virus (RSV) infection.Entities:
Mesh:
Year: 2010 PMID: 20111881 PMCID: PMC2840676 DOI: 10.1007/s10096-009-0865-7
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
Characteristics of infants during the first airway infection
| Characteristics | All infants ( | Rhinovirus detected ( | RSV detected ( |
|---|---|---|---|
| Median age in days (range) | 104 (33–269) | 99 (33–269) | 115 (51–269) |
| Median days of illness at time sampling (range) | 3.5 (2–31)c | 4 (2–16) | 4 (2–12) |
| % male | 58% | 60% | 62% |
| Symptoms | |||
| Rhinorrhoea | |||
| None | 15% | 15% | 18% |
| Mild | 55% | 58% | 46% |
| Moderate–severe | 30% | 27% | 36% |
| Cough | |||
| None | 17% | 18% | 5% |
| Mild | 36% | 46% | 28% |
| Moderate | 37% | 30% | 46% |
| Severe | 10% | 6% | 21% |
| Wheezinga | 8% | 6% | 10% |
| Fever >38°C | 17% | 12% | 23% |
| Hoarseness | 28% | 22% | 31% |
| Apnoeab | 3% | 2% | 5% |
| Cyanosis | 1% | 0% | 3% |
| Retractions | 6% | 3% | 5% |
| Tachypnoea | 20% | 16% | 28% |
| Median sum score (range) | 3 (0–25) | 3 (0–15) | 4 (1–25) |
| 0–4 | 64% | 72% | 56% |
| 5–10 | 25% | 22% | 26% |
| >10 | 11% | 6% | 18% |
The values represent percentages, unless indicated otherwise
aReported by parents
bN = 97
cDuration of illness: IQR = 3–5
Detection of respiratory pathogens and the sensitivity by sampling method
| Respiratory pathogen | NPA ( | NS ( | Total | NPA | NS | ||
|---|---|---|---|---|---|---|---|
| Sensitivity | 95% CI* | Sensitivity | 95% CI* | ||||
| Rhinovirus | 65 | 50 | 67 | 97% | 89.6–99.6 | 75% | 62.5–84.4 |
| RSV | 39 | 20 | 39 | 100% | 91.0–100 | 51% | 34.8–67.6 |
| Coronavirus | 13 | 10 | 14 | 93% | 66.1–99.8 | 71% | 41.9–91.6 |
| Bocavirus | 8 | 7 | 11 | 73% | 39.0–94.0 | 64% | 30.8–89.1 |
| Adenovirus | 9 | 6 | 11 | 82% | 48.2–97.7 | 55% | 23.4–83.3 |
| Parainfluenza type 2 and 4 | 9 | 9 | 11 | 82% | 48.2–97.7 | 82% | 48.2–97.7 |
| hMPV | 4 | 3 | 5 | 80% | 28.4–99.5 | 60% | 14.7–94.7 |
|
| 2 | 2 | 3 | 67% | 9.4–99.2 | 67% | 9.4–99.2 |
|
| 1 | 2 | 2 | 50% | 1.2–98.7 | 100% | 15.8–100 |
| Total | 150 | 109 | 163 | 92% | 86.7–95.7 | 67% | 59.1–74.0 |
NPA: nasopharyngeal aspirate; NS: nasal swab; RSV: respiratory syncytial virus; hMPV: human metapneumovirus; CI: confidence interval
*A one-sided 97.5% confidence interval was used in case the sensitivity was 100%
Sensitivity of the NPA and NS for the detection of rhinovirus and RSV presented by age group, gender, symptom score, presence of multiple pathogens and CT-value of the NPA
| Respiratory pathogen | subgroups | NPA | NTS | Total | NPA | NS | ||
|---|---|---|---|---|---|---|---|---|
| (n) | (n) | Sensitivity | 95% CIa | Sensitivity | 95% CIa | |||
|
| ||||||||
| Age | 1–3 months | 28 | 24 | 28 | 100% | 87.7–100 | 86% | 67.3–96.0 |
| 3–6 months | 30 | 22 | 32 | 94% | 79.2–99.2 | 69% | 50.0–83.9 | |
| 6–12 months | 7 | 4 | 7 | 100% | 59.0–100 | 57% | 18.4–90.1 | |
| Gender | Boy | 38 | 32 | 40 | 95% | 83.1–99.4 | 80% | 64.4–90.0 |
| Girl | 27 | 18 | 27 | 100% | 82.1–100 | 67% | 46.0–83.5 | |
| Symptom score | 0 to 4 | 46 | 36 | 48 | 96% | 85.7–99.5 | 75% | 60.4–86.4 |
| 5 to 10 | 15 | 11 | 15 | 100% | 78.2–100 | 73% | 44.9–92.2 | |
| over 11 | 4 | 3 | 4 | 100% | 39.8–100 | 75% | 19.4–99.4 | |
| Multiple pathogen | No | 29 | 25 | 29 | 100% | 88.1–100 | 86% | 68.3–96.1 |
| Yes | 36 | 25 | 38 | 95% | 82.3–99.4 | 66% | 48.7–80.4 | |
| CT NPAb | 0–20 | 3 | 3 | 3 | 100% | 29.2–100 | 100% | 29.2–100 |
| 20–25 | 22 | 22 | 22 | 100% | 84.6–100 | 100% | 84.6–100 | |
| 25–30 | 17 | 15 | 17 | 100% | 80.4–100 | 88% | 63.6–98.5 | |
| 30–35 | 10 | 6 | 10 | 100% | 69.2–100 | 60% | 26.2–87.8 | |
| 35–40 | 10 | 2 | 10 | 100% | 69.2–100 | 20% | 2.5–55.6 | |
| 40–45 | 3 | 0 | 3 | 100% | 2.9–100 | 0% | 0–70.8 | |
|
| ||||||||
| Age | 1–3 months | 12 | 7 | 12 | 100% | 73.5–100 | 58% | 27.7–84.8 |
| 3–6 months | 20 | 11 | 20 | 100% | 82.3–100 | 55% | 31.5–77.0 | |
| 6–12 months | 7 | 2 | 7 | 100% | 59.0–100 | 29% | 7.6–64.8 | |
| Gender | Boy | 24 | 11 | 24 | 100% | 85.8–100 | 46% | 25.6–67.2 |
| Girl | 15 | 9 | 15 | 100% | 78.2–100 | 60% | 32.3–83.4 | |
| Symptom score | 0 to 4 | 22 | 8 | 22 | 100% | 84.6–100 | 36% | 17.2–59.3 |
| 5 to 10 | 10 | 5 | 10 | 100% | 69.2–100 | 50% | 18.7–81.3 | |
| over 11 | 7 | 7 | 7 | 100% | 59.0–100 | 100% | 59.0–100 | |
| Multiple pathogen | No | 11 | 10 | 11 | 100% | 71.5–100 | 91% | 58.7–99.8 |
| Yes | 28 | 10 | 28 | 100% | 87.7–100 | 36% | 18.6–56.0 | |
| CT NPAb | 0–20 | 4 | 4 | 4 | 100% | 39.8–100 | 100% | 39.8–100 |
| 20–25 | 11 | 10 | 11 | 100% | 71.5–100 | 91% | 58.7–99.8 | |
| 25–30 | 4 | 4 | 4 | 100% | 39.8–100 | 100% | 39.8–100 | |
| 30–35 | 7 | 1 | 7 | 100% | 59.0–100 | 14% | 0.4–57.9 | |
| 35–40 | 10 | 0 | 10 | 100% | 69.2–100 | 0% | 0–30.8 | |
| 40–45 | 3 | 1 | 3 | 100% | 29.2–100 | 33% | 0.8–90.6 | |
NPA nasopharyngeal aspirate; NS nasal swab; RSV respiratory syncytial virus; CT Cycle threshold value
aOne-sided 97.5% confidence interval was used in case sensitivity was 100%
bThe CT-value of the NPA was used as a reference to compare with NS, therefore the sensitivity of the NPA is 100% for all categories